The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Tesaro
Stock and Other Ownership Interests - tesaro
Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer.
 
Hendrik-Tobias Arkenau
No Relationships to Disclose
 
Jasgit C. Sachdev
No Relationships to Disclose
 
Monica M. Mita
No Relationships to Disclose
 
Rafal Dziadziuszko
No Relationships to Disclose
 
Chia-Chi Lin
No Relationships to Disclose
 
James CH Yang
No Relationships to Disclose
 
Jeffrey R. Infante
No Relationships to Disclose
 
Stephen Patrick Anthony
No Relationships to Disclose
 
Mark Voskoboynik
No Relationships to Disclose
 
Wu-Chou Su
No Relationships to Disclose
 
Javier De Castro
No Relationships to Disclose
 
Ronald B. Natale
No Relationships to Disclose
 
Zhi-Yi Zhang
Employment - Tesaro
Stock and Other Ownership Interests - Tesaro
 
Lorraine Hughes
No Relationships to Disclose
 
Dmitri Bobilev
Employment - tesaro
Stock and Other Ownership Interests - Tesaro
 
Glen J. Weiss
Employment - Cancer Treament Centers of America
Consulting or Advisory Role - Pharmatech
Speakers' Bureau - Amgen; Celgene; Pfizer; Quintiles
Travel, Accommodations, Expenses - Cambridge Healthtech Institute; Pharmatech